New nanopore DNA sequencing technology on a device the size of a USB stick could be used to diagnose infection – according to new research from the University of East Anglia and Public Health England.
Researchers tested the new technology with a complex problem – determining the cause of antibiotic resistance in a new multi-drug resistant strain of the bacterium that causes Typhoid.
The results, published today in the journal Nature Biotechnology, reveal that the small, accessible and cost effective technology could revolutionise genomic sequencing.
Current technology for ‘long read’ detailed genomic sequencing can be performed using expensive instrumentation (around £500,000). It is complex to perform, and generally only available in specialist laboratories.
The research team tested a new device called MinION, produced by Oxford Nanopore Technologies Ltd. The machine produces long sequencing reads using a different methodology that does not require optical imaging – but at a small fraction of the instrument cost (expected to be around £650 per device). These long reads are important when trying to determine where resistance genes are.
Researchers proved its utility by successfully mapping the multi-drug resistance genes in a strain called Salmonella Typhi haplotype H58 – which has recently emerged globally.
They successfully pinpointed the exact spot in the chromosomal structure that is home to the genes which makes it drug-resistant, known as an antibiotic resistance island. The MinION took just 18 hours to produce the results, with similar accuracy to current technologies.
Lead researcher Dr Justin O’Grady, from UEA’s Norwich Medical School, said: “This type of technology will revolutionise the way that we characterise the rapid spread of emerging antibiotic-resistant infectious diseases.
“This analysis would previously have taken months using traditional methods, due to extensive post-sequencing lab-based analysis. By the time the results are available, they might well be irrelevant for clinical diagnostics and guiding public health interventions.
“This is the first published research in the world to demonstrate the huge potential of MinION sequencing to solve important and complex biological problems.
“Public health and clinical laboratories could soon have easy access to this rapid, cheap technology which, in combination with short read sequencing, is capable of providing fully assembled bacterial genomes. Further improvements to the system are likely to remove the need for short read sequence data.
“MinION technology could potentially enable bacterial identification, diagnosis of infectious diseases and detection of drug-resistance at the point of clinical need.
“This type of technology makes next generation sequencing accessible to scientists everywhere.”
Read more: UEA research could revolutionise genomic sequencing of drug-resistant bacteria
The Latest on: Nanopore DNA sequencing
[google_news title=”” keyword=”Nanopore DNA sequencing” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Nanopore DNA sequencing
- New DNA origami technique promises advances in medicineon May 9, 2024 at 7:04 am
Dr. Rusling added, "What is really exciting about this technique is that it did not change the underlying origami DNA sequence, offering the ability to use these structures as carriers for synthetic ...
- How Are Nanopores Used in Protein Analysis?on May 7, 2024 at 6:23 am
Nanopores revolutionize protein analysis with single-molecule sensitivity, enabling real-time, label-free detection for advanced biomedical research.
- DNA Sequencing Market Size Anticipated to Soar to New Heights in the Futureon May 5, 2024 at 2:46 pm
Request To Download Free Sample of This Strategic Report @:- https://reportocean.com/industry-verticals/sample-request?report_id=bw1696 ...
- Targeted DNA RNA Sequencing Market To Reach USD 51.3 Billion By 2032 | DataHorizzon Researchon May 4, 2024 at 9:30 pm
The targeted DNA RNA sequencing market size was valued at USD 14.7 Billion in 2023 and is expected to reach a market size of USD 51.3 Billion by 2032 with a CAGR of 14.9%.Fort Collins, Colorado, May ...
- Down 51% in 2024, is this UK growth stock a buy for my Stocks and Shares ISA?on April 28, 2024 at 11:05 pm
Ben McPoland considers Oxford Nanopore Technologies (LSE:ONT), a UK growth stock that has plunged over 80% since going public in 2021. The post Down 51% in 2024, is this UK growth stock a buy for my ...
- Nanopore DNA Sequencing: A Powerful Tool for Genetic Analysison April 26, 2024 at 8:54 am
What is Nanopore DNA Sequencing? Nanopore DNA sequencing is a cutting-edge technology that enables the direct, real-time analysis of long DNA or RNA fragments. Unlike conventional sequencing methods ...
- What Does DNA Stand For, and How Does It Work?on April 21, 2024 at 5:09 am
Scientists use various approaches to sequence a DNA sample, including Sanger sequencing, shotgun sequencing, and the nanopore method. Different methods of DNA sequencing have different strengths.
- Oxford Nanopore Technologieson April 18, 2024 at 3:26 am
The PromethION 2 Integrated sets a new standard for convenience and efficiency in DNA ... highlight how the Oxford Nanopore platform can generate richer data revealing enhanced biological insights not ...
- Nanopore sequencing unveils novel telomere length patternson April 12, 2024 at 10:39 am
To make such precise measurements at the molecular level, Greider's team used a technique invented at UC Santa Cruz called "nanopore sequencing," a revolutionary method for reading DNA and RNA ...
via Bing News